COM:DIAMEDICA
DiaMedica Therapeutics Inc.
- Stock
market
STOCKSindustry
Biopharmaceuticalswebsite
diamedica.comcrunchbase
diamedicaipo date
Aug 03, 2012
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase...Show More